跳至主要内容
临床试验/EUCTR2015-000197-35-IT
EUCTR2015-000197-35-IT进行中(未招募)不适用

insulin resistance, obesity and gastrointestinal bacteria - HR-HP-14-01

AOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI0 个研究点目标入组 100 人开始时间: 2016年3月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • proven hyper-insulinismo (using OGTT)
  • BMI> 24.9 kg / m2 and <39.9 kg / m2
  • Age = 18 years and = 65
  • Informed consent 1 [ for the immunoassay on stool]
  • Informed consent 2 [for Visit1 enrollment]
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients who have already performed a therapy for the eradication of Helicobacter pylori, including proton pump inhibitors, preparations of bismuth, prokinetic or antibiotics in the two previous months;
  • Patients who make use of drugs including anti-inflammatory and / or aspirin, glucose and lipid-lowering agents; alcohol addiction; previous gastric surgery; decompensated congestive heart failure; liver cirrhosis; chronic renal failure; diagnosis of cancer; pregnancy; systemic or local infections
  • Women of childbearing potential not using contraception and breastfeeding women;
  • Known or suspected hypersensitivity to the drug or drug class in the studio;
  • Patients with serious medical conditions that, in the opinion of the investigator, contraindicate the patient's participation in the study;
  • Use of experimental drugs in the last three months prior to study entry.

研究者

发起方
AOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI

相似试验

insulin resistance, obesity and gastrointestinal... | 临床试验